Clinical Trial Update: Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263) [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing efficacy and safety of Fosamax Plus D in postmenopausal osteoporosis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Fosamax Plus D (Alendronate Sodium and Cholecalciferol)

Snippet

Sponsor: Organon and Co | Conditions: Osteoporosis Postmenopausal | Phase 4 | Status: COMPLETED | Results posted: 2010-04-02